Public Affairs Strategy as a Necessity for the Pharmaceutical Industry

Recent developments in the global pharmaceutical market demonstrate that lobbying and public affairs strategies are increasingly becoming critical “weapons” for companies. With the ongoing bargaining between pharmaceutical manufacturers and the U.S. under Trump unsettling international markets, it is clear that companies no longer rely solely on innovative products or local market access strategies; they are…

Pitching at any cost?

We rarely deal with industry-specific issues in this space. However, current events sometimes leave us no choice! EACA (European Association of Communications Agencies) recently published the first pan-European survey on the cost of participating in advertising pitches, bringing to light the large – often unseen – burden borne by advertising agencies. Based on responses from…

AI: Sky (and regulation) is the limit!

Recently, many people have certainly been informed of the extra-ordinary news about the adventure of Marill Garnreiter, who attributed a series of her symptoms to stress, but ChatGTP diagnosed a year before the doctors that she was suffering from an aggressive form of cancer! Obviously, the power of the news lies in the fact that…